Page last updated: 2024-10-25

amphetamine and MEA 2b

amphetamine has been researched along with MEA 2b in 1 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopra, J1
Villarta-Aguilera, M1
Savolainen, M1
Weingerl, S1
Myöhänen, TT1
Rannanpää, S1
Salvatore, MF1
Andressoo, JO1
Piepponen, TP1

Other Studies

1 other study available for amphetamine and MEA 2b

ArticleYear
Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.
    Neuropharmacology, 2018, Volume: 128

    Topics: Amphetamine; Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant

2018